RadioMedix, Inc. is a biotechnology company, based in Houston, Texas, focused on innovative targeted radio-pharmaceuticals for diagnosis, monitoring and therapy of cancer. The company is commercializing generator-produced radio-pharmaceuticals based on Gallium-68 chemistry. RadioMedix is in late-stage development of a new radio-labeled analog targeting metabolic pathway, GlucoMedix, which is based on its patented DO2A-chelation technology. RadioMedix is introducing the SmartMedix™ automated laboratory system for synthesis of PET tracers for the research and clinical markets. RadioMedix has also established two service facilities for academic and industrial partners: cGMP Manufacturing Suite for clinical probe development and Molecular Imaging Facility for evaluation of agents in animal models.
View Top Employees from Radiomedix, Inc.Website | http://www.radiomedix.com |
Revenue | $2 million |
Employees | 40 (35 on RocketReach) |
Founded | 2006 |
Address | 9701 Richmond Avenue Suite 222, Houston, Texas 77030, US |
Phone | (713) 358-6500 |
Technologies |
JavaScript,
HTML,
Twitter
+20 more
(view full list)
|
Industry | Biotechnology Research, Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare |
Competitors | Actinogen Medical, Angiochem, Destiny Pharma plc, Patrys Limited, Precision Biologics |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Radiomedix, Inc. employee's phone or email?
The Radiomedix, Inc. annual revenue was $2 million in 2024.
Azar Delpassand is the Director of Strategic Planning of Radiomedix, Inc..
35 people are employed at Radiomedix, Inc..
Radiomedix, Inc. is based in Houston, Texas.
The NAICS codes for Radiomedix, Inc. are [32541, 3254, 32, 325].
The SIC codes for Radiomedix, Inc. are [28, 283].